Neuroacanthocytosis Syndromes
Neuroacanthocytosis (NA) syndromes are a group of genetically defined diseases characterized by the association of red blood cell acanthocytosis and progressive degeneration of the basal ganglia. NA syndromes are exceptionally rare with an estimated prevalence of less than 1 to 5 per 1'000'...
Uložené v:
| Vydané v: | Orphanet journal of rare diseases Ročník 6; číslo 1; s. 68 |
|---|---|
| Hlavní autori: | , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
London
BioMed Central
25.10.2011
BioMed Central Ltd Springer Nature B.V BMC |
| Predmet: | |
| ISSN: | 1750-1172, 1750-1172 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Neuroacanthocytosis (NA) syndromes are a group of genetically defined diseases characterized by the association of red blood cell acanthocytosis and progressive degeneration of the basal ganglia. NA syndromes are exceptionally rare with an estimated prevalence of less than 1 to 5 per 1'000'000 inhabitants for each disorder. The core NA syndromes include autosomal recessive chorea-acanthocytosis and X-linked McLeod syndrome which have a Huntington´s disease-like phenotype consisting of a choreatic movement disorder, psychiatric manifestations and cognitive decline, and additional multi-system features including myopathy and axonal neuropathy. In addition, cardiomyopathy may occur in McLeod syndrome. Acanthocytes are also found in a proportion of patients with autosomal dominant Huntington's disease-like 2, autosomal recessive pantothenate kinase-associated neurodegeneration and several inherited disorders of lipoprotein metabolism, namely abetalipoproteinemia (Bassen-Kornzweig syndrome) and hypobetalipoproteinemia leading to vitamin E malabsorption. The latter disorders are characterized by a peripheral neuropathy and sensory ataxia due to dorsal column degeneration, but movement disorders and cognitive impairment are not present. NA syndromes are caused by disease-specific genetic mutations. The mechanism by which these mutations cause neurodegeneration is not known. The association of the acanthocytic membrane abnormality with selective degeneration of the basal ganglia, however, suggests a common pathogenetic pathway. Laboratory tests include blood smears to detect acanthocytosis and determination of serum creatine kinase. Cerebral magnetic resonance imaging may demonstrate striatal atrophy. Kell and Kx blood group antigens are reduced or absent in McLeod syndrome. Western blot for chorein demonstrates absence of this protein in red blood cells of chorea-acanthocytosis patients. Specific genetic testing is possible in all NA syndromes. Differential diagnoses include Huntington disease and other causes of progressive hyperkinetic movement disorders. There are no curative therapies for NA syndromes. Regular cardiologic studies and avoidance of transfusion complications are mandatory in McLeod syndrome. The hyperkinetic movement disorder may be treated as in Huntington disease. Other symptoms including psychiatric manifestations should be managed in a symptom-oriented manner. NA syndromes have a relentlessly progressive course usually over two to three decades. |
|---|---|
| AbstractList | Neuroacanthocytosis (NA) syndromes are a group of genetically defined diseases characterized by the association of red blood cell acanthocytosis and progressive degeneration of the basal ganglia. NA syndromes are exceptionally rare with an estimated prevalence of less than 1 to 5 per 1'000'000 inhabitants for each disorder. The core NA syndromes include autosomal recessive chorea-acanthocytosis and X-linked McLeod syndrome which have a Huntington´s disease-like phenotype consisting of a choreatic movement disorder, psychiatric manifestations and cognitive decline, and additional multi-system features including myopathy and axonal neuropathy. In addition, cardiomyopathy may occur in McLeod syndrome. Acanthocytes are also found in a proportion of patients with autosomal dominant Huntington's disease-like 2, autosomal recessive pantothenate kinase-associated neurodegeneration and several inherited disorders of lipoprotein metabolism, namely abetalipoproteinemia (Bassen-Kornzweig syndrome) and hypobetalipoproteinemia leading to vitamin E malabsorption. The latter disorders are characterized by a peripheral neuropathy and sensory ataxia due to dorsal column degeneration, but movement disorders and cognitive impairment are not present. NA syndromes are caused by disease-specific genetic mutations. The mechanism by which these mutations cause neurodegeneration is not known. The association of the acanthocytic membrane abnormality with selective degeneration of the basal ganglia, however, suggests a common pathogenetic pathway. Laboratory tests include blood smears to detect acanthocytosis and determination of serum creatine kinase. Cerebral magnetic resonance imaging may demonstrate striatal atrophy. Kell and Kx blood group antigens are reduced or absent in McLeod syndrome. Western blot for chorein demonstrates absence of this protein in red blood cells of chorea-acanthocytosis patients. Specific genetic testing is possible in all NA syndromes. Differential diagnoses include Huntington disease and other causes of progressive hyperkinetic movement disorders. There are no curative therapies for NA syndromes. Regular cardiologic studies and avoidance of transfusion complications are mandatory in McLeod syndrome. The hyperkinetic movement disorder may be treated as in Huntington disease. Other symptoms including psychiatric manifestations should be managed in a symptom-oriented manner. NA syndromes have a relentlessly progressive course usually over two to three decades. Neuroacanthocytosis (NA) syndromes are a group of genetically defined diseases characterized by the association of red blood cell acanthocytosis and progressive degeneration of the basal ganglia. NA syndromes are exceptionally rare with an estimated prevalence of less than 1 to 5 per 1'000'000 inhabitants for each disorder. The core NA syndromes include autosomal recessive chorea-acanthocytosis and X-linked McLeod syndrome which have a Huntington's disease-like phenotype consisting of a choreatic movement disorder, psychiatric manifestations and cognitive decline, and additional multi-system features including myopathy and axonal neuropathy. In addition, cardiomyopathy may occur in McLeod syndrome. Acanthocytes are also found in a proportion of patients with autosomal dominant Huntington's disease-like 2, autosomal recessive pantothenate kinase-associated neurodegeneration and several inherited disorders of lipoprotein metabolism, namely abetalipoproteinemia (Bassen-Kornzweig syndrome) and hypobetalipoproteinemia leading to vitamin E malabsorption. The latter disorders are characterized by a peripheral neuropathy and sensory ataxia due to dorsal column degeneration, but movement disorders and cognitive impairment are not present. NA syndromes are caused by disease-specific genetic mutations. The mechanism by which these mutations cause neurodegeneration is not known. The association of the acanthocytic membrane abnormality with selective degeneration of the basal ganglia, however, suggests a common pathogenetic pathway. Laboratory tests include blood smears to detect acanthocytosis and determination of serum creatine kinase. Cerebral magnetic resonance imaging may demonstrate striatal atrophy. Kell and Kx blood group antigens are reduced or absent in McLeod syndrome. Western blot for chorein demonstrates absence of this protein in red blood cells of chorea-acanthocytosis patients. Specific genetic testing is possible in all NA syndromes. Differential diagnoses include Huntington disease and other causes of progressive hyperkinetic movement disorders. There are no curative therapies for NA syndromes. Regular cardiologic studies and avoidance of transfusion complications are mandatory in McLeod syndrome. The hyperkinetic movement disorder may be treated as in Huntington disease. Other symptoms including psychiatric manifestations should be managed in a symptom-oriented manner. NA syndromes have a relentlessly progressive course usually over two to three decades. Abstract Neuroacanthocytosis (NA) syndromes are a group of genetically defined diseases characterized by the association of red blood cell acanthocytosis and progressive degeneration of the basal ganglia. NA syndromes are exceptionally rare with an estimated prevalence of less than 1 to 5 per 1'000'000 inhabitants for each disorder. The core NA syndromes include autosomal recessive chorea-acanthocytosis and X-linked McLeod syndrome which have a Huntington´s disease-like phenotype consisting of a choreatic movement disorder, psychiatric manifestations and cognitive decline, and additional multi-system features including myopathy and axonal neuropathy. In addition, cardiomyopathy may occur in McLeod syndrome. Acanthocytes are also found in a proportion of patients with autosomal dominant Huntington's disease-like 2, autosomal recessive pantothenate kinase-associated neurodegeneration and several inherited disorders of lipoprotein metabolism, namely abetalipoproteinemia (Bassen-Kornzweig syndrome) and hypobetalipoproteinemia leading to vitamin E malabsorption. The latter disorders are characterized by a peripheral neuropathy and sensory ataxia due to dorsal column degeneration, but movement disorders and cognitive impairment are not present. NA syndromes are caused by disease-specific genetic mutations. The mechanism by which these mutations cause neurodegeneration is not known. The association of the acanthocytic membrane abnormality with selective degeneration of the basal ganglia, however, suggests a common pathogenetic pathway. Laboratory tests include blood smears to detect acanthocytosis and determination of serum creatine kinase. Cerebral magnetic resonance imaging may demonstrate striatal atrophy. Kell and Kx blood group antigens are reduced or absent in McLeod syndrome. Western blot for chorein demonstrates absence of this protein in red blood cells of chorea-acanthocytosis patients. Specific genetic testing is possible in all NA syndromes. Differential diagnoses include Huntington disease and other causes of progressive hyperkinetic movement disorders. There are no curative therapies for NA syndromes. Regular cardiologic studies and avoidance of transfusion complications are mandatory in McLeod syndrome. The hyperkinetic movement disorder may be treated as in Huntington disease. Other symptoms including psychiatric manifestations should be managed in a symptom-oriented manner. NA syndromes have a relentlessly progressive course usually over two to three decades. Neuroacanthocytosis (NA) syndromes are a group of genetically defined diseases characterized by the association of red blood cell acanthocytosis and progressive degeneration of the basal ganglia. NA syndromes are exceptionally rare with an estimated prevalence of less than 1 to 5 per 1'000'000 inhabitants for each disorder. The core NA syndromes include autosomal recessive chorea-acanthocytosis and X-linked McLeod syndrome which have a Huntington's disease-like phenotype consisting of a choreatic movement disorder, psychiatric manifestations and cognitive decline, and additional multi-system features including myopathy and axonal neuropathy. In addition, cardiomyopathy may occur in McLeod syndrome. Acanthocytes are also found in a proportion of patients with autosomal dominant Huntington's disease-like 2, autosomal recessive pantothenate kinase-associated neurodegeneration and several inherited disorders of lipoprotein metabolism, namely abetalipoproteinemia (Bassen-Kornzweig syndrome) and hypobetalipoproteinemia leading to vitamin E malabsorption. The latter disorders are characterized by a peripheral neuropathy and sensory ataxia due to dorsal column degeneration, but movement disorders and cognitive impairment are not present. NA syndromes are caused by disease-specific genetic mutations. The mechanism by which these mutations cause neurodegeneration is not known. The association of the acanthocytic membrane abnormality with selective degeneration of the basal ganglia, however, suggests a common pathogenetic pathway. Laboratory tests include blood smears to detect acanthocytosis and determination of serum creatine kinase. Cerebral magnetic resonance imaging may demonstrate striatal atrophy. Kell and Kx blood group antigens are reduced or absent in McLeod syndrome. Western blot for chorein demonstrates absence of this protein in red blood cells of chorea-acanthocytosis patients. Specific genetic testing is possible in all NA syndromes. Differential diagnoses include Huntington disease and other causes of progressive hyperkinetic movement disorders. There are no curative therapies for NA syndromes. Regular cardiologic studies and avoidance of transfusion complications are mandatory in McLeod syndrome. The hyperkinetic movement disorder may be treated as in Huntington disease. Other symptoms including psychiatric manifestations should be managed in a symptom-oriented manner. NA syndromes have a relentlessly progressive course usually over two to three decades.Neuroacanthocytosis (NA) syndromes are a group of genetically defined diseases characterized by the association of red blood cell acanthocytosis and progressive degeneration of the basal ganglia. NA syndromes are exceptionally rare with an estimated prevalence of less than 1 to 5 per 1'000'000 inhabitants for each disorder. The core NA syndromes include autosomal recessive chorea-acanthocytosis and X-linked McLeod syndrome which have a Huntington's disease-like phenotype consisting of a choreatic movement disorder, psychiatric manifestations and cognitive decline, and additional multi-system features including myopathy and axonal neuropathy. In addition, cardiomyopathy may occur in McLeod syndrome. Acanthocytes are also found in a proportion of patients with autosomal dominant Huntington's disease-like 2, autosomal recessive pantothenate kinase-associated neurodegeneration and several inherited disorders of lipoprotein metabolism, namely abetalipoproteinemia (Bassen-Kornzweig syndrome) and hypobetalipoproteinemia leading to vitamin E malabsorption. The latter disorders are characterized by a peripheral neuropathy and sensory ataxia due to dorsal column degeneration, but movement disorders and cognitive impairment are not present. NA syndromes are caused by disease-specific genetic mutations. The mechanism by which these mutations cause neurodegeneration is not known. The association of the acanthocytic membrane abnormality with selective degeneration of the basal ganglia, however, suggests a common pathogenetic pathway. Laboratory tests include blood smears to detect acanthocytosis and determination of serum creatine kinase. Cerebral magnetic resonance imaging may demonstrate striatal atrophy. Kell and Kx blood group antigens are reduced or absent in McLeod syndrome. Western blot for chorein demonstrates absence of this protein in red blood cells of chorea-acanthocytosis patients. Specific genetic testing is possible in all NA syndromes. Differential diagnoses include Huntington disease and other causes of progressive hyperkinetic movement disorders. There are no curative therapies for NA syndromes. Regular cardiologic studies and avoidance of transfusion complications are mandatory in McLeod syndrome. The hyperkinetic movement disorder may be treated as in Huntington disease. Other symptoms including psychiatric manifestations should be managed in a symptom-oriented manner. NA syndromes have a relentlessly progressive course usually over two to three decades. |
| Audience | Academic |
| Author | Danek, Adrian Walker, Ruth H Jung, Hans H |
| AuthorAffiliation | 2 Department of Neurology, Ludwig-Maximilians-Universität, München, Germany 1 Department of Neurology, University Hospital Zürich, Zürich, Switzerland 3 Department of Neurology, Veterans Affairs Medical Center, Bronx, NY, USA |
| AuthorAffiliation_xml | – name: 3 Department of Neurology, Veterans Affairs Medical Center, Bronx, NY, USA – name: 2 Department of Neurology, Ludwig-Maximilians-Universität, München, Germany – name: 1 Department of Neurology, University Hospital Zürich, Zürich, Switzerland |
| Author_xml | – sequence: 1 givenname: Hans H surname: Jung fullname: Jung, Hans H email: hans.jung@usz.ch organization: Department of Neurology, University Hospital Zürich – sequence: 2 givenname: Adrian surname: Danek fullname: Danek, Adrian organization: Department of Neurology, Ludwig-Maximilians-Universität – sequence: 3 givenname: Ruth H surname: Walker fullname: Walker, Ruth H organization: Department of Neurology, Veterans Affairs Medical Center |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22027213$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1ks1rFTEUxQep2A_dulNEF-Ji2iR3JsnbCKVUfVAUrK5DJh_TPOYlNcmI779vxldfO8WSRcLN75wbTu5hteeDN1X1EqNjjDk9waxFNcaM1LSm_El1sCvs3TvvV4cprRBqWkD8WbVPCCKMYDioXn01YwxSSZ-vgtrkkFx6c7nxOoa1Sc-rp1YOyby43Y-qn5_Of5x9qS--fV6enV7UirY017LjHVfIMmnBYF2KpEEIJALcMdtZstCosZJZDbRrFWgOHIhloBswHACOquXWVwe5EtfRrWXciCCd-FsIsRcyZqcGIxTrDHSMWoZswzHugHAKjWQUsCGtLl4ft17XY7c2WhmfoxxmpvMb765EH34LIJjwBS0G728NYvg1mpTF2iVlhkF6E8YkFghouyAwkW8fkKswRl-SKhBhnNOWFejdFupleb7zNpSuarIUp9MnYMTYZHX8H6osbdZOlT-3rtRngg8zQWGy-ZN7OaYklpff5-zr-5Hssvg3BnfdVQwpRWN3CEZimjMxjZKYRklQQXkRNA8EymWZXZgidcPjspOtLBV_35t4F9gjihs5Wt_k |
| CitedBy_id | crossref_primary_10_1136_practneurol_2015_001191 crossref_primary_10_3389_fnins_2024_1394478 crossref_primary_10_3390_jpm11050392 crossref_primary_10_1002_mds_25849 crossref_primary_10_1002_ajh_23414 crossref_primary_10_3389_fmed_2018_00198 crossref_primary_10_1136_pn_2023_003981 crossref_primary_10_1179_2151090315Y_0000000027 crossref_primary_10_7759_cureus_62004 crossref_primary_10_3389_fnins_2020_00048 crossref_primary_10_1093_labmed_lmab124 crossref_primary_10_1016_j_ajpath_2013_11_013 crossref_primary_10_1016_j_bbamem_2020_183349 crossref_primary_10_1002_mds_26527 crossref_primary_10_3389_fneur_2025_1643889 crossref_primary_10_31083_j_jin_2019_02_165 crossref_primary_10_1016_j_remnie_2016_02_002 crossref_primary_10_1186_s12881_020_0983_8 crossref_primary_10_1002_mdc3_12312 crossref_primary_10_1007_s00438_024_02111_y crossref_primary_10_1002_acn3_511 crossref_primary_10_1016_j_drudis_2014_03_005 crossref_primary_10_1146_annurev_cellbio_120420_014634 crossref_primary_10_1212_WNL_0000000000012663 crossref_primary_10_18214_jend_2021_00031 crossref_primary_10_3389_fneur_2024_1482936 crossref_primary_10_1111_trf_14119 crossref_primary_10_1016_j_jns_2018_02_005 crossref_primary_10_1212_NXG_0000000000000328 crossref_primary_10_1152_physrev_00020_2015 crossref_primary_10_1016_j_ejmg_2017_12_007 crossref_primary_10_1371_journal_pone_0079241 crossref_primary_10_1016_j_clinimag_2025_110568 crossref_primary_10_1097_MD_0000000000014050 crossref_primary_10_1016_j_jns_2014_01_034 crossref_primary_10_3390_metabo9060113 crossref_primary_10_4103_ijnpnd_ijnpnd_52_24 crossref_primary_10_1016_j_parkreldis_2019_02_024 crossref_primary_10_4103_ccd_ccd_207_20 crossref_primary_10_1007_s10545_013_9665_4 crossref_primary_10_1212_NXG_0000000000000332 crossref_primary_10_1017_S031716710001739X crossref_primary_10_1159_000500951 crossref_primary_10_1016_j_radcr_2024_10_007 crossref_primary_10_3390_genes12030344 crossref_primary_10_1016_j_parkreldis_2017_05_013 crossref_primary_10_1111_ner_12763 crossref_primary_10_1186_s40478_021_01181_y crossref_primary_10_1097_WCO_0b013e3283632d90 crossref_primary_10_1515_tnsci_2022_0249 crossref_primary_10_1111_jopr_12479 crossref_primary_10_1016_j_jns_2014_02_027 crossref_primary_10_1177_25152564231215133 crossref_primary_10_1007_s00415_022_11200_0 crossref_primary_10_1212_WNL_0000000000000144 crossref_primary_10_1097_MOH_0000000000000035 crossref_primary_10_1212_CON_0000000000000349 crossref_primary_10_1136_bcr_2013_200205 crossref_primary_10_3233_JND_200507 crossref_primary_10_4103_0028_3886_226444 crossref_primary_10_4103_neuroindia_NI_574_20 crossref_primary_10_1016_j_pediatrneurol_2014_06_001 crossref_primary_10_1016_j_parkreldis_2021_05_015 crossref_primary_10_1155_2018_9513946 crossref_primary_10_1155_2019_5947416 crossref_primary_10_3389_fphys_2022_884690 crossref_primary_10_1371_journal_pone_0309594 crossref_primary_10_1523_JNEUROSCI_0456_16_2016 crossref_primary_10_1517_17530059_2012_704017 crossref_primary_10_3389_fneur_2024_1377377 crossref_primary_10_1016_j_clineuro_2016_05_028 crossref_primary_10_1016_j_parkreldis_2017_10_016 crossref_primary_10_1186_s40001_022_00646_7 crossref_primary_10_1007_s13760_024_02655_1 crossref_primary_10_1182_blood_2016_07_727321 crossref_primary_10_1007_s40272_022_00517_y crossref_primary_10_1016_j_mehy_2016_02_001 crossref_primary_10_1136_bcr_2014_205232 crossref_primary_10_1212_CON_0000000000000763 crossref_primary_10_3390_genes11070828 crossref_primary_10_1371_journal_pone_0125861 crossref_primary_10_1371_journal_pone_0125580 crossref_primary_10_3390_ijms222212274 crossref_primary_10_1182_blood_2018_05_850255 crossref_primary_10_1002_ams2_815 crossref_primary_10_1016_j_transci_2015_04_007 crossref_primary_10_3389_fneur_2024_1352467 crossref_primary_10_3390_brainsci15040347 crossref_primary_10_3389_fnins_2022_913401 crossref_primary_10_1016_j_jns_2016_09_008 crossref_primary_10_3389_fphys_2022_852946 crossref_primary_10_3390_e14081399 crossref_primary_10_1016_j_clineuro_2019_105421 crossref_primary_10_1016_j_nbd_2023_106292 crossref_primary_10_2217_nmt_2023_0011 crossref_primary_10_1002_mdc3_12698 crossref_primary_10_1002_2211_5463_13870 crossref_primary_10_1016_j_heliyon_2024_e39128 crossref_primary_10_1080_13554794_2021_2024858 crossref_primary_10_1177_1756285612471700 crossref_primary_10_1002_mdc3_12614 |
| Cites_doi | 10.1111/j.1423-0410.1961.tb03203.x 10.1002/mus.1154 10.1002/ana.21081 10.1002/mus.10199 10.1016/j.parkreldis.2007.10.006 10.1212/01.wnl.0000250356.78092.cc 10.1002/mds.870090303 10.1111/j.1423-0410.1981.tb00728.x 10.1002/mds.21915 10.1002/mds.1109 10.1002/mds.21417 10.1111/j.1528-1167.2005.65804.x 10.1002/mds.23052 10.1007/s10048-005-0220-9 10.1016/0092-8674(94)90136-8 10.1002/ana.20200 10.1002/mds.1188 10.1016/j.ijcard.2007.07.167 10.1056/NEJMoa020817 10.1007/BF00314025 10.1111/j.1399-0004.2008.00981.x 10.1002/ana.20248 10.1002/mds.1260 10.1038/88825 10.1002/mds.21725 10.1002/mds.21046 10.1007/s00415-005-0616-3 10.1111/j.1423-0410.2007.00949.x |
| ContentType | Journal Article |
| Copyright | Jung et al; licensee BioMed Central Ltd. 2011 COPYRIGHT 2011 BioMed Central Ltd. 2011 Jung et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Copyright ©2011 Jung et al; licensee BioMed Central Ltd. 2011 Jung et al; licensee BioMed Central Ltd. |
| Copyright_xml | – notice: Jung et al; licensee BioMed Central Ltd. 2011 – notice: COPYRIGHT 2011 BioMed Central Ltd. – notice: 2011 Jung et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. – notice: Copyright ©2011 Jung et al; licensee BioMed Central Ltd. 2011 Jung et al; licensee BioMed Central Ltd. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM ISR 3V. 7T5 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AN0 AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/1750-1172-6-68 |
| DatabaseName | Springer Nature OA Free Journals (WRLC) CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Science ProQuest Central (Corporate) Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland British Nursing Database ProQuest Central Essentials - QC ProQuest Central ProQuest One ProQuest Central Korea ProQuest Health & Medical Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database Proquest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition British Nursing Index with Full Text ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: ProQuest Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1750-1172 |
| EndPage | 68 |
| ExternalDocumentID | oai_doaj_org_article_c7be3b76f70f4811b328634a7631e25d PMC3212896 2506940151 A272110776 22027213 10_1186_1750_1172_6_68 |
| Genre | Journal Article Review |
| GeographicLocations | United States Switzerland Germany |
| GeographicLocations_xml | – name: Switzerland – name: Germany – name: United States |
| GroupedDBID | --- 0R~ 123 29N 2VQ 2WC 4.4 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHSBF AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AN0 AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BNQBC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EBLON EBS EJD EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR INH INR IPNFZ ISR ITC KQ8 M1P M48 MK0 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RIG RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP WOQ WOW ~8M AAYXX AFFHD CITATION EBD ALIPV CGR CUY CVF ECM EIF NPM 3V. 7T5 7XB 8FK AZQEC DWQXO H94 K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c656t-ab8b8c0f7af3e1dc6524003a031b7fbf29d04fa7fd36b5c3d83832f73d43e8333 |
| IEDL.DBID | BENPR |
| ISICitedReferencesCount | 130 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000296856200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1750-1172 |
| IngestDate | Fri Oct 03 12:40:33 EDT 2025 Tue Nov 04 01:54:56 EST 2025 Fri Sep 05 08:33:41 EDT 2025 Sat Oct 25 01:10:00 EDT 2025 Tue Nov 11 10:14:57 EST 2025 Tue Nov 04 17:07:57 EST 2025 Thu Nov 13 14:57:47 EST 2025 Thu Apr 03 07:05:45 EDT 2025 Tue Nov 18 22:26:19 EST 2025 Sat Nov 29 03:40:32 EST 2025 Sat Sep 06 07:29:02 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Huntington Disease Chronic Granulomatous Disease Dystonia Neurodegeneration With Brain Iron Accumulation Hyperkinetic Movement Disorder |
| Language | English |
| License | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c656t-ab8b8c0f7af3e1dc6524003a031b7fbf29d04fa7fd36b5c3d83832f73d43e8333 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | https://www.proquest.com/docview/902788657?pq-origsite=%requestingapplication% |
| PMID | 22027213 |
| PQID | 902788657 |
| PQPubID | 76088 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_c7be3b76f70f4811b328634a7631e25d pubmedcentral_primary_oai_pubmedcentral_nih_gov_3212896 proquest_miscellaneous_903659236 proquest_journals_902788657 gale_infotracmisc_A272110776 gale_infotracacademiconefile_A272110776 gale_incontextgauss_ISR_A272110776 pubmed_primary_22027213 crossref_primary_10_1186_1750_1172_6_68 crossref_citationtrail_10_1186_1750_1172_6_68 springer_journals_10_1186_1750_1172_6_68 |
| PublicationCentury | 2000 |
| PublicationDate | 2011-10-25 |
| PublicationDateYYYYMMDD | 2011-10-25 |
| PublicationDate_xml | – month: 10 year: 2011 text: 2011-10-25 day: 25 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Orphanet journal of rare diseases |
| PublicationTitleAbbrev | Orphanet J Rare Dis |
| PublicationTitleAlternate | Orphanet J Rare Dis |
| PublicationYear | 2011 |
| Publisher | BioMed Central BioMed Central Ltd Springer Nature B.V BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V – name: BMC |
| References | 10.1186/1750-1172-6-68-B6 10.1186/1750-1172-6-68-B10 10.1186/1750-1172-6-68-B32 10.1186/1750-1172-6-68-B11 10.1186/1750-1172-6-68-B17 10.1186/1750-1172-6-68-B39 10.1186/1750-1172-6-68-B18 10.1186/1750-1172-6-68-B19 10.1186/1750-1172-6-68-B14 10.1186/1750-1172-6-68-B36 10.1186/1750-1172-6-68-B15 10.1186/1750-1172-6-68-B37 10.1186/1750-1172-6-68-B16 - 10.1186/1750-1172-6-68-B20 10.1186/1750-1172-6-68-B42 10.1186/1750-1172-6-68-B21 10.1186/1750-1172-6-68-B44 10.1186/1750-1172-6-68-B23 10.1186/1750-1172-6-68-B40 10.1186/1750-1172-6-68-B41 10.1186/1750-1172-6-68-B4 10.1186/1750-1172-6-68-B28 10.1186/1750-1172-6-68-B29 10.1186/1750-1172-6-68-B46 10.1186/1750-1172-6-68-B1 10.1186/1750-1172-6-68-B25 10.1186/1750-1172-6-68-B47 5677189 - Arch Neurol. 1968 Oct;19(4):403-9 17516481 - Mov Disord. 2007 Jul 30;22(10):1416-23 15293285 - Ann Neurol. 2004 Aug;56(2):299-302 10882128 - Mol Cell. 2000 Mar;5(3):423-33 11562915 - Muscle Nerve. 2001 Oct;24(10):1346-51 13860532 - Vox Sang. 1961 Sep;6:555-60 15918062 - Neurogenetics. 2005 Sep;6(3):151-8 5636069 - Arch Neurol. 1968 Feb;18(2):134-40 16060937 - Epilepsia. 2005 Aug;46(8):1256-63 11381254 - Nat Genet. 2001 Jun;28(2):121-2 12510040 - N Engl J Med. 2003 Jan 2;348(1):33-40 15654559 - J Neurol. 2005 Jan;252(1):84-90 18058950 - Mov Disord. 2008 Feb 15;23(3):422-5 12210375 - Muscle Nerve. 2002 Sep;26(3):424-7 2427665 - J Neurol. 1986 Aug;233(4):228-32 11381253 - Nat Genet. 2001 Jun;28(2):119-20 17189525 - J Histochem Cytochem. 2007 Apr;55(4):365-74 18314374 - Parkinsonism Relat Disord. 2008;14(5):440-2 11746618 - Mov Disord. 2001 Sep;16(5):882-9 11761463 - Ann Neurol. 2001 Dec;50(6):373-80 11391763 - Mov Disord. 2001 May;16(3):572-5 11940688 - Neurology. 2002 Apr 9;58(7):1031-7 18045706 - Int J Cardiol. 2009 Feb 6;132(1):130-2 11835468 - Mov Disord. 2002 Jan;17(1):204-7 18341606 - Clin Genet. 2008 May;73(5):480-5 14557581 - Neurology. 2003 Oct 14;61(7):1002-4 16874760 - Mov Disord. 2006 Oct;21(10):1728-31 18181206 - Mov Disord. 2008 Apr 15;23(5):716-20 12499498 - Neurology. 2002 Dec 24;59(12):1982-4 17379193 - Brain Res. 2007 May 25;1147:12-24 11761473 - Ann Neurol. 2001 Dec;50(6):755-64 8004674 - Cell. 1994 Jun 17;77(6):869-80 15468075 - Ann Neurol. 2004 Nov;56(5):670-4 8041370 - Mov Disord. 1994 May;9(3):297-304 17683354 - Vox Sang. 2007 Aug;93(2):112-21 7197431 - Vox Sang. 1981;40(6):403-11 11261514 - Ann Neurol. 2001 Mar;49(3):384-92 10371080 - J Neurol Sci. 1999 Mar 1;163(2):175-8 18055495 - Brain. 2007 Dec;130(Pt 12):3285-96 20544815 - Mov Disord. 2010 Jul 30;25(10):1487-91 17210889 - Neurology. 2007 Jan 9;68(2):92-8 1998879 - Brain. 1991 Feb;114 ( Pt 1A):13-49 19938148 - Mov Disord. 2010 Jan 15;25(1):127-9 17387722 - Ann Neurol. 2007 Mar;61(3):272-82 |
| References_xml | – ident: 10.1186/1750-1172-6-68-B4 doi: 10.1111/j.1423-0410.1961.tb03203.x – ident: 10.1186/1750-1172-6-68-B32 doi: 10.1002/mus.1154 – ident: 10.1186/1750-1172-6-68-B37 doi: 10.1002/ana.21081 – ident: 10.1186/1750-1172-6-68-B28 doi: 10.1002/mus.10199 – ident: 10.1186/1750-1172-6-68-B14 doi: 10.1016/j.parkreldis.2007.10.006 – ident: 10.1186/1750-1172-6-68-B1 doi: 10.1212/01.wnl.0000250356.78092.cc – ident: 10.1186/1750-1172-6-68-B44 doi: 10.1002/mds.870090303 – ident: 10.1186/1750-1172-6-68-B6 doi: 10.1111/j.1423-0410.1981.tb00728.x – ident: 10.1186/1750-1172-6-68-B20 doi: 10.1002/mds.21915 – ident: 10.1186/1750-1172-6-68-B46 doi: 10.1002/mds.1109 – ident: 10.1186/1750-1172-6-68-B36 doi: 10.1002/mds.21417 – ident: 10.1186/1750-1172-6-68-B21 doi: 10.1111/j.1528-1167.2005.65804.x – ident: 10.1186/1750-1172-6-68-B23 doi: 10.1002/mds.23052 – ident: 10.1186/1750-1172-6-68-B16 doi: 10.1007/s10048-005-0220-9 – ident: 10.1186/1750-1172-6-68-B11 doi: 10.1016/0092-8674(94)90136-8 – ident: 10.1186/1750-1172-6-68-B40 doi: 10.1002/ana.20200 – ident: 10.1186/1750-1172-6-68-B25 doi: 10.1002/mds.1188 – ident: 10.1186/1750-1172-6-68-B29 doi: 10.1016/j.ijcard.2007.07.167 – ident: - doi: 10.1056/NEJMoa020817 – ident: 10.1186/1750-1172-6-68-B15 doi: 10.1007/BF00314025 – ident: 10.1186/1750-1172-6-68-B19 doi: 10.1111/j.1399-0004.2008.00981.x – ident: 10.1186/1750-1172-6-68-B18 doi: 10.1002/ana.20248 – ident: 10.1186/1750-1172-6-68-B47 doi: 10.1002/mds.1260 – ident: 10.1186/1750-1172-6-68-B10 doi: 10.1038/88825 – ident: 10.1186/1750-1172-6-68-B42 doi: 10.1002/mds.21725 – ident: 10.1186/1750-1172-6-68-B41 doi: 10.1002/mds.21046 – ident: 10.1186/1750-1172-6-68-B39 doi: 10.1007/s00415-005-0616-3 – ident: 10.1186/1750-1172-6-68-B17 doi: 10.1111/j.1423-0410.2007.00949.x – reference: 15293285 - Ann Neurol. 2004 Aug;56(2):299-302 – reference: 17210889 - Neurology. 2007 Jan 9;68(2):92-8 – reference: 10371080 - J Neurol Sci. 1999 Mar 1;163(2):175-8 – reference: 15468075 - Ann Neurol. 2004 Nov;56(5):670-4 – reference: 11381253 - Nat Genet. 2001 Jun;28(2):119-20 – reference: 1998879 - Brain. 1991 Feb;114 ( Pt 1A):13-49 – reference: 8004674 - Cell. 1994 Jun 17;77(6):869-80 – reference: 17683354 - Vox Sang. 2007 Aug;93(2):112-21 – reference: 11261514 - Ann Neurol. 2001 Mar;49(3):384-92 – reference: 16874760 - Mov Disord. 2006 Oct;21(10):1728-31 – reference: 5677189 - Arch Neurol. 1968 Oct;19(4):403-9 – reference: 11746618 - Mov Disord. 2001 Sep;16(5):882-9 – reference: 18055495 - Brain. 2007 Dec;130(Pt 12):3285-96 – reference: 18314374 - Parkinsonism Relat Disord. 2008;14(5):440-2 – reference: 15654559 - J Neurol. 2005 Jan;252(1):84-90 – reference: 11761463 - Ann Neurol. 2001 Dec;50(6):373-80 – reference: 7197431 - Vox Sang. 1981;40(6):403-11 – reference: 18181206 - Mov Disord. 2008 Apr 15;23(5):716-20 – reference: 12210375 - Muscle Nerve. 2002 Sep;26(3):424-7 – reference: 19938148 - Mov Disord. 2010 Jan 15;25(1):127-9 – reference: 8041370 - Mov Disord. 1994 May;9(3):297-304 – reference: 11391763 - Mov Disord. 2001 May;16(3):572-5 – reference: 11835468 - Mov Disord. 2002 Jan;17(1):204-7 – reference: 12499498 - Neurology. 2002 Dec 24;59(12):1982-4 – reference: 18058950 - Mov Disord. 2008 Feb 15;23(3):422-5 – reference: 12510040 - N Engl J Med. 2003 Jan 2;348(1):33-40 – reference: 11381254 - Nat Genet. 2001 Jun;28(2):121-2 – reference: 13860532 - Vox Sang. 1961 Sep;6:555-60 – reference: 17387722 - Ann Neurol. 2007 Mar;61(3):272-82 – reference: 11761473 - Ann Neurol. 2001 Dec;50(6):755-64 – reference: 20544815 - Mov Disord. 2010 Jul 30;25(10):1487-91 – reference: 5636069 - Arch Neurol. 1968 Feb;18(2):134-40 – reference: 17379193 - Brain Res. 2007 May 25;1147:12-24 – reference: 2427665 - J Neurol. 1986 Aug;233(4):228-32 – reference: 17516481 - Mov Disord. 2007 Jul 30;22(10):1416-23 – reference: 18045706 - Int J Cardiol. 2009 Feb 6;132(1):130-2 – reference: 11562915 - Muscle Nerve. 2001 Oct;24(10):1346-51 – reference: 16060937 - Epilepsia. 2005 Aug;46(8):1256-63 – reference: 17189525 - J Histochem Cytochem. 2007 Apr;55(4):365-74 – reference: 15918062 - Neurogenetics. 2005 Sep;6(3):151-8 – reference: 10882128 - Mol Cell. 2000 Mar;5(3):423-33 – reference: 11940688 - Neurology. 2002 Apr 9;58(7):1031-7 – reference: 14557581 - Neurology. 2003 Oct 14;61(7):1002-4 – reference: 18341606 - Clin Genet. 2008 May;73(5):480-5 |
| SSID | ssj0045308 |
| Score | 2.3759034 |
| SecondaryResourceType | review_article |
| Snippet | Neuroacanthocytosis (NA) syndromes are a group of genetically defined diseases characterized by the association of red blood cell acanthocytosis and... Abstract Neuroacanthocytosis (NA) syndromes are a group of genetically defined diseases characterized by the association of red blood cell acanthocytosis and... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 68 |
| SubjectTerms | Abetalipoproteinemia - genetics Abetalipoproteinemia - pathology Abetalipoproteinemia - therapy Adult Basal Ganglia - pathology Child Cognition Disorders - genetics Cognition Disorders - pathology Cognition Disorders - therapy Creatine kinase Degeneration Female Gene mutations Genealogy Genetics Genotype & phenotype Human Genetics Humans Hypobetalipoproteinemias - genetics Hypobetalipoproteinemias - pathology Hypobetalipoproteinemias - therapy Kinases Male Medical research Medicine Medicine & Public Health Movement Disorders - genetics Movement Disorders - pathology Movement Disorders - therapy Mutation Nervous system Neuroacanthocytosis - classification Neuroacanthocytosis - genetics Neuroacanthocytosis - pathology Neuroacanthocytosis - physiopathology Neurodegeneration Neurology Ostomy Pharmacology/Toxicology Physiological aspects Rare diseases Review Syndrome |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fa9UwFA4yRHwRf1u3yUUEfQlrc9IkfZziUNAhTmVvIUkbd2G0st4r7L_fOW1uvZ2KL74mpyH5kpNz0nPyhbEXptC6qqTjQpuGSxUcN84FDhF8pKQAP9xK-_ZBHx-b09Pq09ZTX5QTNtIDj8AdBO0b8FpFnUdpisKDMAqkQ70oGlHWtPui17M5TI17sCxheIsObWPOC7TRia6xMOpgKuOKE8HqljkaWPt_35u3jNP1xMlr0dPBKB3dZXeSN7k4HEdxj91o2vvs1scUL3_A9gfuDUfwnXXhctX1y35xkkgK-ofs69HbL2_e8fQgAg_odq2488abkEftIjRFjYWUAQoOFdPriNhWdS6j07EG5csAtcHzp4gaagmNAYBHbKft2uYJW2ALUjoZQKH_BwK3XxdyWdeVC1o46TLGN7jYkNjC6dGKczucGoyyhCNRhQurrDIZeznJ_xh5Mv4q-ZpgnqSI33oowFm3adbtv2Y9Y89pkiwxWLSUIvPdrfvevj_5bA_FeKjVCvuUhGKHfccRjjcOEAEivZpJ7s0kUcXCrHp3sxZsUvHeVhSzNarUGVtMtfQhZa21TbcmEaCoNWADj8eFM41a0E8nUUDG9GxJzWCZ17TLs4H-G9DbMBW2-Wqz-H516s-QP_0fkO-y2yLlP4pyj-2sLtbNPrsZfq6W_cWzQf2uAOSvLUw priority: 102 providerName: Directory of Open Access Journals – databaseName: Springer LINK Contemporary dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3daxQxEA-1ivTF7-raVg4R9CW4m8km2ccqFgUt0tPSt5DNJu2B7JbbO8H_3kk2e7qtgr5uJmEymY9kZ_ILIS9UIWVVcUOZVI5yYQ1VxlgKHmofigLqeCvt9KM8PlZnZ9XnLZKPd2FitfuYkoyeOpq1Eq8xzuW0wHhLBRXqBrmJoU4FUzyZn46-l5eQqwTNeL3PJPREhP7rfvi3QHS1SPJKpjQGoKO7_8_6PXInbTZnh4N23Cdbrn1Abn9K6fSH5CBCc5gg3YvO_lh1_aKfzROGQf-IfD169-Xte5reS6AWd2UrampVK5t7aTy4osGPoUAUDNptLT2Kvmpy7o30DYi6tNAoPJ4yL6Hh4BQA7JLttmvdEzLDETg33ILA7SEw9M7G5rxpKmMlM9xkhI6i1DaBiYc3Lb7peKhQQoc5ByRxpoUWKiMvN_SXA4zGXynfhJXZUAX46_ihW57rZE3aytpBLYWXueeqKGpgSgA36CwLx8omI8_DuuoAcNGGCppzs-57_WF-og_ZcOaVAnlKRL5D3nGGw4UElEDAxJpQ7k8o0QLtpHlvVB-dPECvq5DSVaKUGZltWkPHUNTWum4dSCAktQEHeDzo2mbWLPyTYgVkRE60cCKWaUu7uIjo4ICbEVXhmK9GXfzF1J9F_vTfSffIDktFkKzcJ9ur5dodkFv2-2rRL59FW_wJrxktNw priority: 102 providerName: Springer Nature |
| Title | Neuroacanthocytosis Syndromes |
| URI | https://link.springer.com/article/10.1186/1750-1172-6-68 https://www.ncbi.nlm.nih.gov/pubmed/22027213 https://www.proquest.com/docview/902788657 https://www.proquest.com/docview/903659236 https://pubmed.ncbi.nlm.nih.gov/PMC3212896 https://doaj.org/article/c7be3b76f70f4811b328634a7631e25d |
| Volume | 6 |
| WOSCitedRecordID | wos000296856200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMedCentral customDbUrl: eissn: 1750-1172 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0045308 issn: 1750-1172 databaseCode: RBZ dateStart: 20060101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1750-1172 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0045308 issn: 1750-1172 databaseCode: DOA dateStart: 20060101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1750-1172 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0045308 issn: 1750-1172 databaseCode: M~E dateStart: 20060101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1750-1172 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0045308 issn: 1750-1172 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1750-1172 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0045308 issn: 1750-1172 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Publicly Available Content Database customDbUrl: eissn: 1750-1172 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0045308 issn: 1750-1172 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: Springer LINK Contemporary customDbUrl: eissn: 1750-1172 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0045308 issn: 1750-1172 databaseCode: RSV dateStart: 20061201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9sgEEdrOk176T67em2jaJq0vaDaHAH8NLVTq1VaoyjZquwJYWzaSJPdxcmk_ffjHJzV3cfLXiwBZwTHcQfc8YOQ1yqRMk25oUyqgnJhDVXGWAoOModBAVlzK-3yoxyN1GyWjkNsTh3CKlud2CjqvLJ4Rn6UootMiaF8d_ON4qNR6FwNL2hskW0EKuM9sn1yOhpPWlXMhxCrgNSYKHHkTWVME2-yqaCIrXrLEjWA_b-r5Vt26W7M5B3HaWOPzh79Z08ek52wEB0cryXnCblXlE_Jg4vgan9GDhvYDoOcv67sj2VVz-vBNOAb1M_J57PTT-8_0PCWArV-xbakJlOZsrGTxkGR5D4Tg0fB-DmdSeeHJc1j7ox0OYhsaCFXfuvKnIScQ6EAYJf0yqos9sjA18C54RaEXzoC85rb2JjneWqsZIabiNCWr9oGoHF87-KrbjYcSmgcB0QZZ1pooSLyZkN_s4bY-CvlCQ7ThgqhsZuManGlw0zTVmYFZFI4GTuukiQDpgRw4xVpUrBhHpFXOMgawS9KjK65Mqu61ufTiT5m6_2wFL5NgchVvu2-h-vLCp4DiJfVoTzoUPrZaTvF-60Q6KAdar2RgIgMNqX4Iwa8lUW1QhJAhzf4Cl6sBW_Ta4bnVSyBiMiOSHbY0i0p59cNcjj4hYpKfZ1vW-H91ag_s_zlP9u_Tx6yEBPJhgekt1ysikNy335fzutFn2zJmWy-qh9mZr858_Cp8fnF-ItPTaaXPwGYDUCl |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LbxMxELaqFAEX3tDQFiIEgovVXduxvQeEyqNq1CSKaEHtyXi96zZStVuyCag_iv_IzD5CtzxuPXC1Z63Z8XhmbI-_IeS5DpWKImEpUzqlQjpLtbWOcs9jj0kBcfkq7fNQjcf68DCarJAfzVsYTKtsbGJpqJPc4Rn5VoRXZFr21ZuzrxSLRuHlalNBo9KKvfT8O-zYiteD9zC9Lxjb-XDwbpfWRQWog9BlTm2sY-0Cr6znaZhAI2ZRcgvKHSsP_EVJILxVPuEy7jueaNjDMa94IniqOZ5_gsVfFaDrukNWJ4PR5Kgx_aLPA10jQ4ZaboFrDmgIIQKVFLFcL3i-skDA727ggh-8nKN56aK29H87t_8zyd0ht-pAu7ddrYy7ZCXN7pHrozqV4D7ZLGFJLGrWSe7O53kxLXr7NX5D8YB8uhLmHpJOlmfpGunBCEJY4biE0Jgz8EzWBSJJIusUs8J2CW3m0bgaSB3reZyackOlpcF5RxR1ZqSRukteLunPKgiRv1K-RbVYUiH0d9mQz45NbUmMU3HKYyW9CrzQYRhzpiUXFhxFmLJ-0iXPUKkMgntkmD10bBdFYQb7H802q_b7SgJPNZHPgXf4w-oxBkgA8cBalBstSrA-rtW93iidqa1fYZYa1yW9ZS9-iAl9WZovkITjhT6HAR5Vir78a4bncSzkXaJaS6AllnZPNj0pkdE5BGI6gjFfNYvlF1N_Fvnjf_L_lNzYPRgNzXAw3lsnN1md_8n6G6Qzny3STXLNfZtPi9mT2hL0yJerXkI_AV-WmOc |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3da9UwFA9zyvBlfru6TS8i6EtYm5MmKfgyPy4O52V4dewtpGmzXZB23PYK_vfmtOnVbgqCr81JSE7OR9Jzzi-EvFCJlFnGDWVSlZQLa6gyxlJwkDtMCsi7qrTTYzmbqbOz7GSDvB5qYbps9yEk2dc0IEpT1R5cFq5XcSUOvM-LaeJ9LxVUqBvkJscHg_CuPj8d7DBPIVYBpvF6n5Eb6tD6r9vk35zS1YTJK1HTzhlN7_zfMu6S7XAInRz2UnOPbJTVfbL1KYTZH5D9DrLDINcvavujrZtFM5kHbIPmIfk6ff_l7Qca3lGg1p_WWmpylSsbO2kclEnhP2LiKBivz7l0fkuyIubOSFeAyFMLhfLXVuYkFBxKBQCPyGZVV-UOmfgRODfcgvDHRmDeahsb86LIjJXMcBMROrBV2wAyjm9dfNPdZUMJjWtGhHGmhRYqIi_X9Jc9vMZfKd_gLq2pEBa7-1Avz3XQMm1lXkIuhZOx4ypJcmBKADfeiCYlS4uIPMc91gh8UWFmzblZNY0-mn_Wh6y_C0vh5xSIXO3n7lfYFyp4DiBW1ohyb0TpNdOOmncHUdLBMjQ6w1CvEqmMyGTdih0x2a0q6xWSAAa7wQ_wuJe79aoZ_qtiCUREjiRyxJZxS7W46FDDwR9SVObHfDXI5a9J_ZnlT_6d9BnZOnk31cdHs4-75DYLeZIs3SOb7XJV7pNb9nu7aJZPOxX9CXm9OP8 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Neuroacanthocytosis+Syndromes&rft.jtitle=Orphanet+journal+of+rare+diseases&rft.au=Jung%2C+Hans+H&rft.au=Danek%2C+Adrian&rft.au=Walker%2C+Ruth+H&rft.date=2011-10-25&rft.pub=Springer+Nature+B.V&rft.eissn=1750-1172&rft.volume=6&rft.spage=68&rft_id=info:doi/10.1186%2F1750-1172-6-68&rft.externalDocID=2506940151 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1750-1172&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1750-1172&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1750-1172&client=summon |